Market Overview

Benzinga's Top Downgrades

Share:
Related ABT
Benzinga's M&A Chatter for Monday February 1, 2015
Mid-Afternoon Market Update: Roper Technologies Falls Following Weak Results; Questar Shares Spike Higher
Valeant's Share Price Continues to Decline (GuruFocus)
Related LLTC
Benzinga's Volume Movers
Linear Tech Cautions 'It Remains Difficult To Forecast In The Current Environment'

Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.

Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.

Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.

Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.

Latest Ratings for ABT

DateFirmActionFromTo
Feb 2016Argus ResearchUpgradesHoldBuy
Jan 2016William BlairDowngradesOutperformMarket Perform
Jan 2016JefferiesMaintainsBuy

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ABT + HAL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters